| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gain Therapeutics, Inc. | Principal Accounting and Financial Officer | Employee Stock Option (right to buy) | 50,000 | $293,000 | $5.86 | 21 Mar 2024 | Direct |
| Gain Therapeutics, Inc. | Principal Accounting and Financial Officer | Employee Stock Option (right to buy) | 50,000 | 20 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GANX | Gain Therapeutics, Inc. | 20 Mar 2025 | 1 | $0 | 4 | Principal Accounting and Financial Officer | 21 Mar 2025, 20:00 |
| GANX | Gain Therapeutics, Inc. | 21 Mar 2024 | 1 | $0 | 4 | Principal Accounting and Financial Officer | 25 Mar 2024, 21:30 |
| GANX | Gain Therapeutics, Inc. | 23 Mar 2023 | 1 | $0 | 4 | Principal Accounting Officer | 27 Mar 2023, 17:27 |
| GANX | Gain Therapeutics, Inc. | 12 Dec 2022 | 0 | $0 | 3 | Principal Accounting Officer | 21 Dec 2022, 15:14 |